Clinical effectiveness of a wearable hydration device
Clinical effectiveness of a wearable hydration device
批准号:
10773374
负责人:
Eamon Johnson
金额:
$5.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-30 至 2023-08-31
关键词:
Academic Medical CentersAccident and Emergency departmentAcuteAftercareAreaBody WaterBusinessesChronic DiseaseClinicalClinical effectivenessCommunicationComputer softwareDehydrationDevelopmentDevicesDiabetes MellitusDiseaseElderlyEmergency CareEnvironmentEvaluationFundingFutureGrantHealthHealthcareHealthcare SystemsHeart DiseasesHomeHydration statusIndividualIndustryInnovation CorpsInstitutional Review BoardsKidney DiseasesLaboratoriesLeadLearningLifeLightLiquid substanceMarketingMeasuresMedicalMigraineMonitorPersonsPhaseProcessProtocols documentationQuality of lifeResearchResourcesSalesSmall Business Technology Transfer ResearchTechniquesTechnologyTimeTrainingWaterWorkcommercializationdesignexperienceextracellularimprovedinnovationmemberprogramsprototypesuccessward
中文摘要
谓词STTR第一阶段拨款和团队的执行摘要
此应用程序寻求补充资金,以围绕创新方法发展我们的业务
测量水合作用。我们公司正在寻求STTR资金,以完善我们的技术和
与学术医疗中心合作,在临床需求较高的领域展示其实用性。
在TritonX,我们相信健康与健康的未来在于持续的监测。监控
对于数百万人来说,补水是一项日常挑战,特别是老年人和患有共同疾病的人
慢性病--偏头痛、肾病、心脏病、糖尿病等严重疾病。我们
开发了一种可穿戴的持续补水监测仪,可以检测用户的全身水分,
实时细胞内外水分,帮助他们过上更好的生活,抵御疾病和
保持或提高他们的生活质量。我们公司寻求消除由以下因素造成的负担
脱水不仅对个人,而且对医疗保健系统都是如此。
朝着我们第一阶段目标的进展:
目标1:确定理想的用户体验、设备设置和医疗保健通信需求
在家中持续监测老年人的体液水平。
进展:我们重新设计了之前的原型设备,删除了不必要的功能和
升级组件,以提高当前研究的效率和可靠性。改进后的设备
将使我们能够更好地关注客户体验,而不是技术支持。
目标2:将设备测量的液体水平与临床和实验室参数进行比较
因脱水而到急诊科就诊的急病老年人的治疗。
进展:我们已经制定了方案,并确定了团队成员在
建议的急救护理环境。IRB审批已完成。我们对员工进行了礼仪方面的培训
使用我们的设备。
I-兵团团队
我们的i-Corps团队:
?公司负责人:TritonX公司首席执行官艾蒙·约翰逊博士
?技术线索:TritonX Inc.首席技术官Shravan Khare
?行业专家:TritonX Inc.顾问格雷格·戴维斯
约翰逊博士和哈雷先生是TritonX Inc.的创始人,他们投入了大量的个人资源
小企业和技术的发展。哈雷先生是这项技术的发明者。戴维斯先生是
他是TritonX的投资者和顾问,在医疗软件销售和营销方面拥有25年的经验。博士
约翰逊和戴维斯在健康软件的研究商业化方面已经密切合作了六年。
该团队致力于公司的成功,并准备完全致力于i-Corps计划。我们
将该计划视为一个重要的学习机会,并满怀期待地期待着
客户发现。我们致力于根据市场情况彻底重新评估我们的价值主张。
我们将通过i-Corps进程发现现实。
英文摘要
Executive Summary of Predicate STTR Phase 1 Grant and Team
This application seeks supplemental funding for growing our business around an innovative approach
to measuring hydration. Our company is seeking STTR funding to refine our technique and
demonstrate its utility in an area of high clinical need, in partnership with an academic medical center.
At TritonX we believe that the future of health & wellness is in continuous monitoring. Monitoring
hydration is a daily challenge for millions of people, especially older adults and people with common
chronic diseases - migraines, kidney disease, heart disease, diabetes and other serious conditions. We
have developed a wearable continuous hydration monitor that can detect users’ total body water,
intracellular and extracellular water in real time to help them lead a better life, ward off diseases and
maintain or improve their quality of life. Our company seeks to eliminate the burdens caused by
dehydration not only on individuals but also on the health care system.
Progress toward aims of our Phase I aims:
Aim 1: Determine the ideal user experience, device settings and health care communication needs
when conducting continuous monitoring of fluid levels among older adults in their homes.
Progress: We have redesigned our prior prototype device, removing unnecessary features and
upgrading components to increase efficiency and reliability for the current study. The improved device
will enable us to better focus on customer experience as opposed to technical support.
Aim 2: Compare device measured fluid levels to clinical and laboratory parameters pre and post
treatment among acutely ill older adults presenting to the emergency department for dehydration.
Progress: We have established protocols and identified team members to conduct our study in the
proposed emergency care environment. IRB approval is complete. We have trained staff on protocols
using our device.
I-Corps Team
Our I-Corps team:
? Corporate Officer: Dr Éamon Johnson, CEO TritonX Inc
? Technical Lead: Shravan Khare, CTO TritonX Inc
? Industry Expert: Greg Davis, advisor to TritonX Inc
Dr Johnson and Mr Khare are founders of TritonX Inc and have devoted substantial personal resources to
development of the small business and the technology. Mr Khare is the inventor of the technology. Mr Davis is
an investor and advisor with TritonX with 25 years of experience in medical software sales and marketing. Dr
Johnson and Mr Davis have worked closely for six years in research commercialization in health software.
The team is committed to the success of the company and ready to commit to the I-Corps program fully. We
view the program as an essential learning opportunity and look forward with great anticipation to the process of
customer discovery. We are committed to thorough re-evaluation of our value proposition in light of the market
reality we will discover through the I-Corps process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical effectiveness of a wearable hydration device
-
批准号:10603046
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2022
-
负责人:Eamon Johnson
-
依托单位: